Login / Signup

Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy.

Shemonti HasanOnilia ZorioB Mark KeeganBrian G WeinshenkerEoin P FlanaganW Oliver TobinOrhun H KantarciMichel ToledanoSean J PittockSebastian Lopez-ChiribogaAnastasia ZekeridouCristina Valencia Sanchez
Published in: Journal of neurology (2023)
Keyphrases
  • disease activity
  • systemic lupus erythematosus
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • ankylosing spondylitis
  • juvenile idiopathic arthritis